A detailed history of Sachetta, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sachetta, LLC holds 5,587 shares of ABBV stock, worth $1.06 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
5,587
Previous 5,267 6.08%
Holding current value
$1.06 Million
Previous $816 Million 28.01%
% of portfolio
0.45%
Previous 0.39%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$154.79 - $180.76 $49,532 - $57,843
320 Added 6.08%
5,587 $1.04 Billion
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $724,739 - $816,226
5,267 New
5,267 $816 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $335B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sachetta, LLC Portfolio

Follow Sachetta, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sachetta, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sachetta, LLC with notifications on news.